Rapid and dramatic radiographic and clinical response to an ALK inhibitor (crizotinib, PF02341066) in an ALK translocation-positive patient with non-small cell lung cancer.
?
['Adult', 'Carcinoma, Non-Small-Cell Lung/*drug therapy/genetics', 'Female', '*Gene Rearrangement', 'Humans', 'Lung Neoplasms/*drug therapy/genetics', 'Positron-Emission Tomography', 'Protein-Tyrosine Kinases/*antagonists & inhibitors/*genetics', 'Proto-Oncogene Proteins/genetics', 'Proto-Oncogene Proteins c-met/genetics', 'Proto-Oncogene Proteins p21(ras)', 'Pyrazoles/*therapeutic use', 'Pyridines/*therapeutic use', 'Receptor Protein-Tyrosine Kinases', 'Receptors, Growth Factor/genetics', 'Tomography, X-Ray Computed', 'ras Proteins/genetics']